Why we're lowering our Bristol Myers price target despite an earnings beat, guidance raise
- Posted on April 24, 2025
- By CNBC
- 7 Views
Why we're lowering our Bristol Myers price target despite an earnings beat, guidance raise
Shares of Bristol Myers Squibb fell modestly after the drugmaker's better-than-expected first-quarter results.
